Procalcitonin: An Effective Biomarker in the Management of Sepsis Patients

Learn about the role procalcitonin has in diagnosing the severity of sepsis patients and assessing treatment success.

Apr 15, 2020

Duration: 32 minutes
P.A.C.E. CE contact hours: 1.0 hours

Click here to watch >

Sepsis is the leading cause of death globally, with an estimated incidence of 18 million cases per year worldwide and a mortality rate of approximately 30% according to the Surviving Sepsis Campaign. This presentation provides an introduction regarding the role of procalcitonin in the management of sepsis, its value as a diagnostic tool and aid for guiding the initiation/discontinuation of antibiotics in critically ill patients.

This program is P.A.C.E. accredited. Users who watch the video and complete the accompanying quiz will receive credit for 1 hour.

Note: P.A.C.E. continuing education credits are only available for registrants in the U.S.

Disclosures: This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.

About our Speaker:
About our Speaker:

Ron Carlton, PhD, MT(ASCP)

Clinical Science Liaison

Ortho Clinical Diagnostics